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Products
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Bioassays for carcinogenicity ofvarious primary processing products (crude oils or tars) and commer-
cial products obtained from Estorian oil shale have been carried out since 1951. The products (undiluted
or diluted) were painted twice weekly 50 times on the interscapular area of the skin of random-bred or
CC57Br mice. The products processed at high temperatures have a higher carcinogenic activity. Blends of
products containing over 10% of high temperature crude oil (chamber furnace oil) have about the same
carcinogenic activity as the latter. There is no strict correlation between the concentration of
benzo(a)pyrene (BP) in oil shale products and their carcinogenic activity. Determination of BP in such
products can serve as an approximate estimate of carcinogenic properties.
The results of animal experiments with chromatographic fractions of the high temperature shale oil
demonstrated the presence ofcompounds which lengthen the latency period of the carcinogenic effect of
BP in the aromatic fraction ofthis oil as well as other carcinogens and compounds enhancing the activity
of carcinogenic compounds.
Under industrial conditions, contact ofworkers withcarcinogenic shale oils can be reduced by means of
coking the carcinogenic oils, which results in production ofsolid coke and ofdistillate which is recycled.
Medical vaseline potentiates the carcinogenic action of BP and similar compounds. Dilution of shale oils
with oils containing aliphatic hydrocarbons cannot be considered as diminution of the carcinogenic
potency of these products.
The main results of animal experiments carried
out since 1951 to determine the carcinogenic po-
tency of various primary and commercial products
of thermolysis of oil shale from deposits in north-
eastern Estonia (USSR) will be briefly sum-
marized. Attention will also be drawn to some
questions ofmore general interest, such as the value
of determination of benzo(a)pyrene (BP) in such
products and the role of solvents.
Previous studies on the carcinogenic action of
Scottish oil shale processing products (1-4) were
familiar to us as were publications on occupational
tumors induced by various tars and oils in the Scot-
tish oil shale industry, cotton spinning, and other
industries (5-9).
The carcinogenic activity ofprimary oil shale tars
from other Soviet oil shale deposits (Veimarn,
Gdov) was comparatively weak (10, 11). Larionov
(12) tested some tars obtained from Estonian oil
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shales and found that only the tar from the chamber
oven pilot plant, produced at temperatures up to
1000°C, possesses carcinogenic properties.
In our earlier experiments we used random-bred
white mice in skin painting experiments. Undiluted
(later also diluted) products were applied twice
weekly (50 times) on the interscapular area of the
skin. Periodic examinations of skin changes and
post mortems with histological investigations of
changes in various organs were performed. In most
cases the BP concentrations in products under in-
vestigation was carried out in the Institute of
Chemistry ofthe Academy ofSciences ofthe Esto-
nian SSR. The criterion of malignancy was the his-
tological demonstration ofpenetration of the tumor
into the muscular layer.
Table I shows the results ofexperiments with six
samples of primary processing products ofoil shale
which we call tars or crudes; ofthese, the chamber
oven tar is processed at about 1000°C, while the
generator, tunnel oven, and solid heat carrier tars
are processed at temperatures ranging from 400 to
5500C.
165The effective number ofmice is the number alive
at the time ofappearance ofthe first tumor. Table 2
presents data on the carcinogenicity of some com-
mercial products. The carcinogenic activity in
commercial products containing the highly car-
cinogenic chamber oven tar is obvious; on the other
hand, the carcinogenicity of various samples of
chamber oven tar is different, and there is no clear
relationship between the proportion of chamber
oven tar in complex mixtures and their carcinogenic
potency.
Table 3 presents data on carcinogenicity of as-
phalts produced by three different methods from
heavy fractions of low temperature tars. The
oxidized (blown) asphalt containing considerably
less BP is less carcinogenic than the bottom asphalt
obtained as residue of vacuum distillation of these
heavy fractions. The cold solvent extraction residue
appeared to be even less carcinogenic, in spite of
slightly higher BP concentration. The light fraction
obtained in the solvent extraction process with ap-
proximately similar BP content had a considerably
stronger carcinogenicity. Apparently the BP con-
centration and carcinogenic potency are not com-
pletely correlated.
Table 4 shows some results of later experiments
by Vinkmann carried out with some commercial
products mostly in CC57Br mice. There is a near,
but not complete, correlation between the BP con-
centration and the carcinogenicity of the product.
Some tars have been repeatedly tested as their
composition was not absolutely constant; the re-
sults however are in general similar.
The main conclusion which can be drawn from
these tests is that the higher carcinogenic activity
occurs in the products processed at high tempera-
ture. Even a blend of tars containing over 10% of
chamber oven tar has about the same carcinogenic
Table 1. Carcinogenicity of primary processing products of oil shale.
Time to No. of mice with
BP, Initial no. of mice, Effective no. first tumor, No. ofmice with malignant
No. Product ppm (random-bred) of mice weeks skin tumors skin tumors
1 Chamber oven tar I 1000 111 88 10 49 27
2 Generator tar 100 105 73 10 21
3 Tunnel oven tar 10 70 34 89 12 2
4 SHC tar (interme- 122 68 13 46 4
diate pilot plant)
5 Chamber oven tar 2 1700 122 74 8 15 7
6 Dephenolated 2000 107 83 10 56 33
chamber oven tar
Table 2. Carcinogenicity of some secondary oil shale processing products.
No. ofmice with
Proportion of Initial no. Effective no. Time offirst No. of mice with malignant
No. Product chamber oven tar, % of mice of mice tumor, weeks skin tumors skin tumors
I Fuel oil 15 170 50 10 23 12
2 Impregnating oil 40 100 13 20 9 2
3 Rubber softening oil 90
4 Printing ink 75
Table 3. Carcinogenicity of oil shale asphalts.
No. ofmice with
Initial Effective Time tofirst No. ofmice with maliant
No. Product BP,ppm no. ofmice no. ofmice tumor, weeks skintumors skintumors
I Bottom asphalt 1000 70a 44 10 24 7
2 Blown asphalt 30 70a 48 15 12 2
3 Solvent extraction 75 501 30 26 1
4 Solvent extraction residue 85 50' 45 12 9 1
light fraction
a Random-bred.
b C57B1 strain.
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tars, being mixtures of numerous different com-
pounds, contain other carcinogenic compounds in
addition to BP. EYsen (13) determined 0.017% BP,
0.46% various derivatives ofBP, 0.3% 1,2-benzo(a)
anthracene, and various other polycyclic aromatic
hydrocarbons in a sample of chamber oven tar.
We carried out experiments with chromato-
graphic fractions of aromatic compounds of the
chamber oven tar containing various amounts ofBP
in order to ascertain whether these fractions also
contain compounds having anti- or cocarcinogenic
properties. The fractions were diluted in benzene
(3%), and a positive control group was included in
which mice were painted with a 0.2% BP solution in
benzene. Table 5 shows that the fractions had a
different carcinogenic activity which is clearer
when the formula ofReissig (14) is applied, showing
the carcinogenic effect.
where
Et = 100 TtI(Ao- Mt)
Tt = Tmt + T7t
Table 4. Carcinogenicity of some newer commercial oil shale products and tars.
No. ofmice
BP, Initialno. Effective Time tofirst No. of mice withmaligant
No. Product ppm ofmice no. ofmice tumor, weeks with skin tumors skintumors
1 Generator tar 68a 61 20 10 6
2 Tunnel oven tar 68a 66 10 10 2
3 Solid heat carrier 68a 67 12 10 6
(SHC) tar
4 Solvent 53a
5 LSP-1 lacquer 500 52a 50 10 45 37
6 Diphenyl ketone resin 50a
1:1 (DFK 4) in acetone
7 DFK-8 48b
1:1 in acetone
8 N12-K 48b
(Tanning reagent)
50% water solution
9 Generator residue 10 50' 50 10 22 15
1:1 in olive oil
10 Polymer residues 8 50-
(from compressors)
1:1 olive oil
11 Tolichton 50a
12 Gas gasoline pyrolytic 2800 52a 50 10 45 37
tar 40o in solvent
13 SHC tar, intermediate 20 32a 15 22 6 0
fraction
14 SHC tar, heavy 30 31a 29 10 11 4
fraction
15 Nerosin 25 62a 49 10 19 7
a CC57Br strain.
b Random-bred
Table 5. Carcinogenicity of 3% benzene solutions of some aromatic fractions of chamber oven tar (70 paintings, random-bred mice).
Total Time to No. of mice with
BP, BP dose, Initial no. Effective first tumor, No. of mice with malignant
No. Product ppm mg of mice No. of mice weeks skin tumors skin tumors
I Fraction 4 - 50 48 52 2
2 Fraction 5 50 48 32 15 7
3 Fraction 6 70 0.193 50 49 32 15 11
4 Fraction 7 2000 5.544 50 48 23 34 24
5 Fraction 8 50 0.139 50 39 32 14 3
6 Fractions 35 0.096 50 48 32 22 12
6-4
(1:1)
7 2% 2000 5.544 50 47 12 33 23
benzene
solution
of BP
167 June 1979and llnt, and Pi are the numbers of tumor-bearing
live and dead mice, respectively, at time t;A, is the
initial number of mice; Mt is the number of dead
mice without tumors at time t; Et is the carcinogenic
effect (in percent) i.e., tumor bearing mice related
to mice liable to develop tumors at time t.
These fractions were also injected intramuscularly
to mice and painted on the skin of rabbits. Some
interesting results were obtained including data on
remote tumors in lungs and on skin mastocytomas,
which have been published elsewhere (15). Figure 1
shows the difference in the development of skin
tumors in mice, presenting the carcinogenic effect.
Fraction 7 with the same amount of BP as the
solution of pure BP in benzene contains probably
compounds lengthening the latency period of the
carcinogenic effect of BP. Fraction 5 without BP
apparently consists of rather active carcinogenic
compounds other than BP and fraction 4 containing
no BP has a moderately enhancing effect on the
action of fraction 6.
We have cooperated in an effort to diminish the
contact of workers with the strongly carcinogenic
chamber oven tar. Together with Kozhevnikov and
Gortalum (16) experiments on coking of the
chamber oven tar, analyses of BP content of the
liquid products involved (initial products and coke
distillate), and experiments on the action ofthe dis-
tillate in comparison with the initial tar on mice
were carried out.
The initial tar contained 2300 ppm BP, the distil-
lation residue (the immediate material for coking)
6400 ppm, the distillate (after coking), 535 ppm BP.
Random-bred mice were painted 50 times (twice
weekly) with 15% benzene solutions ofthe initial tar
and the distillate. The results are shown in Table 6.
The distillate has a considerably weaker car-
cinogenic effect than the initial tar. On the other
hand, the concentration ofBP again does not corre-
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spond to the carcinogenic effect of the products
tested. In this way it is possible to diminish the BP
concentration by approximately one order of mag-
nitude and what is more important, to convert all
highly carcinogenic liquid tars by coking into prod-
ucts less hazardous for workers, as solid coke is less
contaminating and the distillate recycled in a closed
system. It should be added, that since 1964 acoking
department is in operation at the Kohtla-Jarve oil
shale processing plant, utilizing as a rule the whole
amount of produced chamber oven tar.
In the experiments with various fractions of
chamber oven tar and in other experiments it ap-
peared repeatedly that the results of quantitative
determination of BP do not reflect the actual car-
cinogenic potency of the products. Such determi-
nation can be used only as a rough estimate of car-
cinogenic properties. To illustrate this we made
comparisons by plotting some Et curves obtained in
our experiments.
Figure 2 shows that the dephenolated chamber
oven tar, the solution of BP in benzene, and the
fraction 7 of the chamber oven tar, all three con-
taining 2000 ppm BP show different degrees of car-
cinogenic potency, the strongest carcinogenicity
was found in the 15 per cent dilution of chamber
oven tar in medicinal vaseline containing about ten
times less of BP.
Vaseline consists of various aliphatic hy-
drocarbons. The strong potentiating activity of n-
dodecane, one representative of such compounds,
was clearly demonstrated by Bingham and Falk
(17).
These results have substantial practical signifi-
cance, as small amounts of known carcinogenic
compounds may under certain circumstances be
much more dangerous than could be concluded
from their actual concentrations.
Bingham and Falk also discussed the promoting
CHART 2
FIGURE 1. Carcinogenic effect of various fractions of chamber
oven oil.
FIGURE 2. Carcinogenic effect of diluted solutions of various
fractions of chamber oven oil.
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168role of phenols (17).
Our second paper deals with some data on
phenols present in oil shale processing products.
From the theoretical point of view as well as from
various practical aspects it would appear very im-
portant to investigate whether aliphatic hy-
drocarbons act synergistically with the carcinogen,
facilitating its penetration into the cells, or in
another way, do they have a phenollike promoting
action which can manifest itselfafter some time has
passed, after exposure to the carcinogen. It is
necessary to find out whether aliphatic hy-
drocarbons are active as promoters in the sense of
the two-stage scheme of carcinogenicity.
These considerations should be especially taken
into account ifoil shale processing products should
be used as lubricants, cooling mixtures, or cutting
oils. This concerns undoubtedly all mineral oils.
An important practical conclusion can be made
that dilution of oil shale processing products with
"'neutral" products, such as refined mineral oils or
similar, consisting mainly of aliphatic hy-
drocarbons, can by no means be considered as di-
minishing the carcinogenic potency of these prod-
ucts.
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